Proposal to list medical devices supplied by Single Use Dental Instruments Pty Ltd and Defries Industries New Zealand Limited
Pharmac is seeking feedback on a proposal to list a range of medical devices in Part III of Section H of the Pharmaceutical Schedule.
What we’re proposing
Pharmac is seeking feedback on a proposal to list medical devices supplied by Single Use Dental Instruments Pty Ltd (“Single Use Dental Instruments") and Defries Industries New Zealand Limited (“Defries”) in Part III of Section H of the Pharmaceutical Schedule from 1 February 2022 through a non-exclusive provisional agreement.
We propose to list medical devices supplied in the following categories:
Consultation closes at 4pm Tuesday 7 December 2021 and feedback can be emailed to adyam.markos@pharmac.govt.nz.
What would the effect be?
From 1 February 2022 the following medical devices would be listed under proposed national agreements for all DHB Hospitals to purchase under, subject to consultation and approval by Pharmac’s Board or delegate (“Agreements”):
- Dental and oral health products supplied by Single Use Dental Instruments; and
- Dental and oral health products and laboratory equipment and consumables supplied by Defries.
The Agreements would not be for sole supply and DHBs can continue to purchase other suppliers’ brands of dental and oral health products and laboratory equipment and consumables.
The Agreements would supersede any existing DHB agreements with Single Use Dental Instruments and Defries, for products included in the Agreements. Any products listed in the Agreements and purchased by a DHB would be in accordance with the terms and conditions, including price, stated in the Agreements effective from the date of listing in the Pharmaceutical Schedule.
As part of the Agreements Single Use Dental Instruments and Defries would provide appropriate training and education services that would be tailored to the individual needs of DHBs, in formats and at times as required by DHBs.
Pricing for the medical devices in the Agreements, subject to any prior termination of the Agreements, would not be increased without prior consultation and approval by Pharmac.
Who we think will be interested
- DHB clinical staff in a range of different clinical settings including but not limited to:
- Dental Hubs
- Mobile Schools
- Clinicians
- Community Dental Clinics
- Orthodontists
- Laboratory managers, scientists, technicians, and other laboratory staff
- Procurement Officers and supply chain personnel
- Suppliers and wholesalers
About the medical devices
Dental and oral health
The dental and oral health category includes medical devices used in dental settings in DHB hospitals for the management of dental and oral health.
Laboratory equipment and consumables
The Laboratory Equipment and Consumables category includes medical devices used in the collection, receipt, preparation and analysis of human biological material for the purpose of supporting patient diagnosis, management and treatment.
Why we’re proposing this
The RFPs were for non-exclusive national agreements for listing on the Pharmaceutical Schedule.
Pharmac has been working with suppliers who responded to the RFPs and proposals were progressed to contract negotiations to seek provisional agreements.
These proposals are the latest to arise from these processes and we expect to consult on further provisional agreements with the suppliers of dental and oral health products and laboratory equipment and consumables in 2022.
Details about our proposal
The proposal would result in the listing of medical devices in the following brands and quantities:
|
Supplier |
Category |
Line items |
Brands |
|---|---|---|---|
|
Single Use Dental Instruments |
Dental and oral health products |
30 |
Single Use Dental Instruments |
|
Defries |
Dental and oral health products |
12 |
Defries Industries |
|
Defries |
Laboratory equipment and consumables |
10 |
Defries Industries |
Further information, including pricing and contractual details, has been provided to DHB Procurement personnel. Clinicians interested in further detail on what this change means for their DHB should engage with their Procurement teams.
To provide feedback
Send us an email: adyam.markos@pharmac.govt.nz by 4pm 7 December 2021.
All feedback received before the closing date will be considered by PHARMAC’s Board (or its delegate) prior to making a decision on this proposal.
Your feedback may be shared
Feedback we receive is subject to the Official Information Act 1982 (OIA). Please be aware that we may need to share your feedback, including your identity, in response to an OIA request. This applies to anyone providing feedback, whether they are providing feedback themselves or for an organisation, in a personal or professional capacity.
We can only keep feedback confidential as allowed under the OIA and other related laws. If you want any part of your feedback treated as confidential, you need to tell us. Please let us know if you want to keep part of your feedback confidential, and why. Is it commercially sensitive, confidential or proprietary, or personal information? Clearly state this and tell us which parts of your feedback you want to keep confidential for these reasons. We will consider your request under our OIA requirements.